Son-ALS | A therapeutic approach to recurrent transient opening of the blood-brain barrier (BBB) in amyotrophic lateral sclerosis ALS Recruiting
PREMODIALS | Identification of Early Markers for ALS ACT4ALS-MNDIndividuals with ALS risk mutationsALS Recruiting
UNITE-ALS | Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis Phase 2ALS Recruiting
FG-CoALS // Franco-German cohort study to determine factors associated with weight loss in amyotrophic lateral sclerosis ACT4ALS-MNDALS Suspended recruitment
ReALiSe | A Phase 2a, Double-Blinded, Randomized, Placebo-Controlled, and Active-Treatment Extension Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of ARGX-119 in Participants with Amyotrophic Lateral Sclerosis ACT4ALS-MNDPhase 2aALS Completed
ASTRALS // A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis ACT4ALS-MNDPhase 2ALS Interrupted
SEALS | A double-blind, randomized, placebo-controlled, multicentric, phase II study in adult patients with amyotrophic lateral sclerosis (ALS) to assess efficacy, safety, tolerability and pharmacokinetics of multiple intravenous infusions of NX210c. ACT4ALS-MNDPhase 2ALS Preliminary research results available
ALS-Gut // Metagenomic Characterization of the Intestinal Microbiota in ALS Patients and Association with Clinical Phenotypes ALSMicrobiota Coming soon
RNALS | ALS Diagnosis From a Saliva Sample: a Non-coding RNA Analysis Approach ACT4ALS-MNDALS Completed
